Envestnet Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,864
| Closed | -$308K | – | 3389 |
|
|
2020
Q3 | $308K | Sell |
5,864
-4,956
| -46% | -$205K | ﹤0.01% | 2724 |
|
|
2020
Q2 | $360K | Buy |
+10,820
| New | +$345K | ﹤0.01% | 2594 |
|
|
2018
Q3 | – | Sell |
-14,506
| Closed | -$297K | – | 2940 |
|
|
2018
Q2 | $297K | Sell |
14,506
-256
| -2% | -$5.49K | ﹤0.01% | 1517 |
|
|
2018
Q1 | $268K | Buy |
14,762
+1,445
| +11% | +$24.1K | ﹤0.01% | 1456 |
|
|
2017
Q4 | $186K | Sell |
13,317
-1,260
| -9% | -$17K | ﹤0.01% | 1878 |
|
|
2017
Q3 | $269K | Buy |
14,577
+377
| +3% | +$6.3K | ﹤0.01% | 1713 |
|
|
2017
Q2 | $240K | Sell |
14,200
-75
| -0.5% | -$1.14K | ﹤0.01% | 1802 |
|
|
2017
Q1 | $191K | Buy |
14,275
+411
| +3% | +$6.44K | ﹤0.01% | 1944 |
|
|
2016
Q4 | $208K | Sell |
13,864
-508
| -4% | -$6.71K | ﹤0.01% | 1880 |
|
|
2016
Q3 | $168K | Sell |
14,372
-8,443
| -37% | -$99.3K | ﹤0.01% | 2104 |
|
|
2016
Q2 | $246K | Buy |
22,815
+1,662
| +8% | +$17.1K | ﹤0.01% | 1978 |
|
|
2016
Q1 | $195K | Buy |
21,153
+9,254
| +78% | +$99.6K | ﹤0.01% | 2088 |
|
|
2015
Q4 | $177K | Buy |
11,899
+1,195
| +11% | +$20K | ﹤0.01% | 2095 |
|
|
2015
Q3 | $176K | Buy |
10,704
+1,438
| +16% | +$29.4K | ﹤0.01% | 2077 |
|
|
2015
Q2 | $211K | Sell |
9,266
-8,366
| -47% | -$167K | ﹤0.01% | 2109 |
|
|
2015
Q1 | $268K | Buy |
17,632
+11,498
| +187% | +$149K | ﹤0.01% | 1828 |
|
|
2014
Q4 | $74K | Sell |
6,134
-915
| -13% | -$10.5K | ﹤0.01% | 1269 |
|
|
2014
Q3 | $80K | Buy |
+7,049
| New | +$80.4K | ﹤0.01% | 1367 |
|
|
2014
Q1 | – | Sell |
-38
| Closed | -$1K | – | 2673 |
|
|
2013
Q4 | $1K | Buy |
+38
| New | +$639 | ﹤0.01% | 2401 |
|
Envestnet Asset Management's MNTA Position: Q4 2020 in Review
Envestnet Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 5,864 shares — an estimated $308K sold.
Envestnet Asset Management first reported a position in MNTA in Q4 2013 and held it in 19 quarters. The position peaked at $360K in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Envestnet Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Envestnet Asset Management sold 5,864 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $308K.
- Envestnet Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 19 quarters.
- Envestnet Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $360K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Envestnet Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.